DiaSorin S.p.A. (VIE:DIAS)

Austria · Delayed Price · Currency is EUR

62.36

+1.86 (3.07%)

At close: Dec 5, 2025

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2013 - 2020
Italy Revenue	182.68M	176.52M	Log In	Log In	Log In	Upgrade
Europe Revenue	293.02M	288.15M	Log In	Log In	Log In	Upgrade
North America Revenue	641.35M	618.94M	Log In	Log In	Log In	Upgrade
Rest of the World Revenue	98.45M	101.81M	Log In	Log In	Log In	Upgrade

EBIT by Geography

Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2013 - 2020
Italy Operating Profit	99.85M	104.56M	Log In	Log In	Log In	Upgrade
Europe Operating Profit	26.87M	24.35M	Log In	Log In	Log In	Upgrade
North America Operating Profit	151.32M	140.76M	Log In	Log In	Log In	Upgrade
Rest of the World Operating Profit	504.00K	1.27M	Log In	Log In	Log In	Upgrade
Eliminations from Operating Profit	-13.74M	-12.61M	Log In	Log In	Log In	Upgrade

Key Performance Indicators

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	2012 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2012 - 2019
Ex-COVID Immunodiagnostics % of Revenue	66.20%	Log In	Log In	Log In	Upgrade
Ex-COVID Molecular Diagnostics % of Revenue	17.20%	Log In	Log In	Log In	Upgrade
Licensed Technologies % of Revenue	14.40%	Log In	Log In	Log In	Upgrade
COVID % of Revenue	2.20%	Log In	Log In	Log In	Upgrade